Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26083152 | 0.91 | GAA (0.38) | GAAL3MBTL1 | |
| SCHEMBL17931142 | 0.89 | GAA (0.39) | GAAL3MBTL1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL17931125 | 0.88 | GAA (0.42) | GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL26083151 | 0.84 | GAA (0.40) | GAAL3MBTL1 | |
| SCHEMBL12352250 | 0.84 | NAAA (0.48) | — | |
| SCHEMBL17931117 | 0.81 | GAA (0.42) | GAAL3MBTL1 | |
| SCHEMBL18948165 | 0.81 | GAA (0.33) | GAAL3MBTL1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL26082997 | 0.78 | SMN1; SMN2 (0.42) | GAAL3MBTL1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL26083006 | 0.77 | NAAA (0.42) | GAASMN1; SMN2MEN1KMT2A | |
| SCHEMBL26083005 | 0.77 | NAAA (0.42) | GAASMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | HNRNPU, CBR1, CBR3 | GAA 4805/4885L3MBTL1 1314/4885SMN1; SMN2 2128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.